What is the Epidemiological Impact of Nanoparticle-based Adjuvants?
From an epidemiological perspective, nanoparticle-based adjuvants could significantly impact public health by improving vaccine responses in populations with varying levels of immunity. They could enhance herd immunity, especially in vulnerable populations such as the elderly or immunocompromised individuals. Moreover, during pandemics, these adjuvants could expedite vaccine development and distribution, potentially saving millions of lives.
